Athéna earned her B.S. in Chemistry, summa cum laude, at the University of Florida. She joined the Lieberman lab in 2015, and recently graduated with her Ph. D. in Biochemistry. Her research focuses on myocilin antibody development and biophysical characterization of proteins, including X-ray crystallography.
Emily obtained her B.S. degree from University of Connecticut in 2018. She joined Lieberman lab and worked on optimization of a growth protocol for generating high yields of the C-terminus olfactomedin (OLF) domain of myocilin.
Priyam did his B.E. in Biotechnology from Birla Institute of Technology, Mesra, India and is currently pursuing MS in Bioinformatics. He is working on identification of biological substrates for intramembrane aspartyl proteases in Archaea.
Alice received her B.S in Biochemistry at Stetson University, Florida. She is conducting research in myocilin biophysical characterization and antibody development. She started her PhD in the Lieberman lab in 2018.
Yuqi received his B.S. degree in Biology and Chemistry at Emory University. He is currently studying the substrate preferences and activity of intramembrane aspartyl protease. He joined the Lieberman Lab in 2018.
Mingming got his B.E in Biological Engineering from Beijing Institute of Technology, China and is enrolled in the Bioinformatics MS program at Georgia Tech. His main work focuses on phylogenetic analysis of olfactomedins and relative evolutionary problems.
Research Scientists & Postdocs
Shannon started her postdoctoral research in the Lieberman lab in 2011. She is in the myocilin subgroup. In 2016, she started her position as research scientist in the Lieberman group.
Dustin obtained his B.S. in Chemistry, summa cum laude, from Seattle University. He then obtained his M.S. and Ph.D. at the University of California, San Diego with a degree in Chemistry and Biochemistry, specializing in bioinorganic, biophysics, and structural biochemistry. His advisor was Akif Tezcan. He joined the Lieberman Lab in Fall 2013 and is part of the myocilin subgroup.
Dr. Martin received his PhD from Chad Dickey's lab at USF. Prior to joining the Lieberman lab, he did a postdoc at Duke. His current project involves mammalian cell culture assays for myocilin.Max graduated from Morehouse College with a BS in biology and then the University of South Florida with a Masters and PhD in biomedical sciences. His research interests include understanding full length myocilin structure and function in cell models and studying myocilin toxicity.